Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesResident Physicians Knowledge of Risk Factors for Upper Gastrointestinal Complications From NSAIDs
American Journal of Therapeutics, 09/29/09
Cote GA et al. – Senior residents demonstrated marginally better knowledge of risk factors for upper GI complications from NSAIDs. A combined educational intervention and electronic alert did not have a durable impact on knowledge.
Related Articles
Nonsteroidal anti-inflammatory drugs
Cancer, 10/16/09
Relevance Score: 91%
Effect of nonsteroidal anti-inflammatory drug plasters for knee osteoarthritis in Japanese: a randomized controlled trial
Modern Rheumatology, 10/12/09
Relevance Score: 89%
Perioperative Use of Nonsteroidal Anti-Inflammatory Drugs: Results of a UK Regional Audit
Clinical Drug Investigation, 10/15/09
Relevance Score: 88%
Use of Nonsteroidal Antiinflammatory Drugs and Risk of Endometrial Cancer
American Journal of Epidemiology, 11/09/09
Relevance Score: 85%
Ophthalmic utility of topical bromfenac, a twice-daily nonsteroidal anti-inflammatory agent
Expert Opinion in Pharmacotherapy, 10/19/09
Relevance Score: 85%
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
ML17032 trial: capecitabine/cisplatin versus 5-fluorouracil/cisplatin as first-line therapy in advanced gastric cancer
Expert Review of Anticancer Therapy, 12/04/09
Bevacizumab combined with chemotherapy for patients with advanced colorectal cancer: a systematic review
Annals of Oncology, 12/04/09
A phase I study of axitinib (AG-013736) in combination with bevacizumab plus chemotherapy or chemotherapy alone in patients with metastatic colorectal cancer and other solid tumors
Annals of Oncology, 12/04/09
Sponsor
Article Search
Sponsor